Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1993-07-02
1995-12-05
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435212, 435215, C12N 972, C12N 948, A61K 3849
Patent
active
054726921
ABSTRACT:
The invention relates to thrombolytically active pro-urokinase (pro-UK) mutants comprising the amino acid sequence of native pro-UK, but including a mutation which causes the pro-UK mutants to induce less fibrinogenolysis and non-specific plasminogen activation than native pro-UK, to have at least a 10-fold lower intrinsic activity than native pro-UK, and to have substantially the same fibrin promotion and thrombolytic activity after plasmin activation compared to native pro-UK when administered to a patient.
REFERENCES:
patent: 5108901 (1992-04-01), Anderson
Harris, T. J. R. "Second-Generation Plasminogen Activators," Protein Engineering 1(6):449-458 (1987).
Brooks et al., J. Comp. Chem., 4:187-217 (1983).
Heckel et al., J. Comp. Aided Mol. Des., 2:7-14 (1988).
Liu et al., Biochemistry, 31:6311-6317 (1992).
Nienaber et al., Biochemistry, 31:3852-3861 (1992).
Peterson et al., Biochem., 29:3451-57 (1990).
Wang et al. J. Mol. Biol., 185:595-624 (1985).
Gurewich Victor
Liu Jian-Ning
Jacobson Dian C.
New England Deaconess Hospital Corporation
Wax Robert A.
LandOfFree
Pro-urokinase mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pro-urokinase mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro-urokinase mutants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1372270